For: | Anupam K, Tusharkant C, Gupta SD, Ranju R. Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J Gastroenterol 2006; 12(37): 6041-6045 [PMID: 17009406 DOI: 10.3748/wjg.v12.i37.6041] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i37/6041.htm |
Number | Citing Articles |
1 |
Hsi-Wen Yeh, Szu-Shuo Lee, Chieh-Yu Chang, Yaw-Dong Lang, Yuh-Shan Jou. A New Switch for TGFβ in Cancer. Cancer Research 2019; 79(15): 3797 doi: 10.1158/0008-5472.CAN-18-2019
|
2 |
Kai Ma, Baoping Cao, Mingzhou Guo. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Clinical Epigenetics 2016; 8(1) doi: 10.1186/s13148-016-0210-9
|
3 |
L Du, Z Zhao, X Ma, T-H Hsiao, Y Chen, E Young, M Suraokar, I Wistuba, J D Minna, A Pertsemlidis. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer. Oncogene 2014; 33(34): 4307 doi: 10.1038/onc.2013.381
|
4 |
Robert Moore, Kathy Qi Cai, Wensi Tao, Elizabeth R Smith, Xiang-Xi Xu. Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissues. BMC Developmental Biology 2013; 13(1) doi: 10.1186/1471-213X-13-39
|
5 |
Domenico Azarnia Tehran, Tania López-Hernández, Tanja Maritzen. Endocytic Adaptor Proteins in Health and Disease: Lessons from Model Organisms and Human Mutations. Cells 2019; 8(11): 1345 doi: 10.3390/cells8111345
|
6 |
Grégoire F. Le Bras, Kenneth J. Taubenslag, Claudia D. Andl. The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Cell Adhesion & Migration 2012; 6(4): 365 doi: 10.4161/cam.21326
|
7 |
Ya-Fei Xu, Yan-Ping Mao, Ying-Qin Li, Xian-Yue Ren, Qing-Mei He, Xin-Ran Tang, Ying Sun, Na Liu, Jun Ma. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2. Cancer Letters 2015; 363(2): 146 doi: 10.1016/j.canlet.2015.04.006
|
8 |
Gaoda Ju, Lingling Zhang, Wenting Guo, Hao Wang, Xin Zhang, Zhuanzhuan Mu, Yuqing Sun, Di Sun, Han Diao, Sen Miao, Yiran Chen, Tao Xing, Jun Liang, Yansong Lin, Wei Long Zhong. Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid Carcinoma. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/1686316
|
9 |
Beata Pyrzynska, Iwona Pilecka, Marta Miaczynska. Endocytic proteins in the regulation of nuclear signaling, transcription and tumorigenesis. Molecular Oncology 2009; 3(4): 321 doi: 10.1016/j.molonc.2009.06.001
|
10 |
Marc S. Penn. Are stem cells the teacher or the student?. Current Opinion in Organ Transplantation 2012; 17(6): 663 doi: 10.1097/MOT.0b013e32835a5aad
|
11 |
Nidhi N. Shah, Bhavarth P. Dave, Kashvi C. Shah, Disha D. Shah, Kunal G. Maheshwari, Mehul R. Chorawala. RETRACTED ARTICLE: Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution. Cell Biochemistry and Biophysics 2024; 82(2): 501 doi: 10.1007/s12013-024-01261-5
|
12 |
XUE-MEI XIE, ZI-YIN ZHANG, LIAN-HE YANG, DA-LEI YANG, NA TANG, HUAN-YU ZHAO, HONG-TAO XU, QING-CHANG LI, EN-HUA WANG. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers. International Journal of Oncology 2013; 43(5): 1636 doi: 10.3892/ijo.2013.2084
|
13 |
Joanna H Tong, David C Ng, Shuk L Chau, Ken K So, Patrick P Leung, Tin L Lee, Raymond W Lung, Michael W Chan, Anthony W Chan, Kwok W Lo, Ka F To. Putative tumour-suppressor gene DAB2is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-253
|
14 |
Adèle Hannigan, Paul Smith, Gabriela Kalna, Cristiana Lo Nigro, Clare Orange, Darren I. O’Brien, Reshma Shah, Nelofer Syed, Lindsay C. Spender, Blanca Herrera, Johanna K. Thurlow, Laura Lattanzio, Martino Monteverde, Meghan E. Maurer, Francesca M. Buffa, Jelena Mann, David C.K. Chu, Catharine M.L. West, Max Patridge, Karin A. Oien, Jonathan A. Cooper, Margaret C. Frame, Adrian L. Harris, Louise Hiller, Linda J. Nicholson, Milena Gasco, Tim Crook, Gareth J. Inman. Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoter. Journal of Clinical Investigation 2010; 120(8): 2842 doi: 10.1172/JCI36125
|
15 |
Zoe K. Price, Noor A. Lokman, Masato Yoshihara, Hiroaki Kajiyama, Martin K. Oehler, Carmela Ricciardelli. Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways. International Journal of Molecular Sciences 2022; 24(1): 696 doi: 10.3390/ijms24010696
|
16 |
Alicia A. Tone, Carl Virtanen, Patricia Shaw, Theodore J. Brown. Prolonged Postovulatory Proinflammatory Signaling in the Fallopian Tube Epithelium May Be Mediated through a BRCA1/DAB2 Axis. Clinical Cancer Research 2012; 18(16): 4334 doi: 10.1158/1078-0432.CCR-12-0199
|
17 |
S Liu, N Zhu, H Chen. Expression patterns of human DAB2IP protein in fetal tissues. Biotechnic & Histochemistry 2012; 87(5): 350 doi: 10.3109/10520295.2012.664658
|
18 |
O. I. Kit, D. I. Vodolazhskiy, E. N. Kolesnikov, N. N. Timoshkina. Epigenetic markers of esophageal cancer: DNA methylation. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2017; 11(1): 55 doi: 10.1134/S1990750817010048
|
19 |
Chang Li, Jun Chen, Tengfei Chen, Zhenlei Xu, Chun Xu, Cheng Ding, Yuxuan Wang, Jun Zhao, Chang Li, Zhe Lei, Hong-Tao Zhang, Jun Zhao, Chang Li, Zhe Lei, Hong-Tao Zhang, Jun Zhao. Aberrant Hypermethylation at Sites -86 to 226 of DAB2 Gene in Non-Small Cell Lung Cancer. The American Journal of the Medical Sciences 2015; 349(5): 425 doi: 10.1097/MAJ.0000000000000436
|
20 |
J. Chen, D. L. Kwong, T. Cao, Q. Hu, L. Zhang, X. Ming, J. Chen, L. Fu, X. Guan. Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics. Diseases of the Esophagus 2015; 28(1): 84 doi: 10.1111/dote.12088
|
21 |
Chang Li, Cheng Ding, Tengfei Chen, Jun Chen, Zhenlei Xu, Zhe Lei, Chun Xu, Jun Zhao. Micro ribonucleic acid‐93 promotes proliferation and migration of esophageal squamous cell carcinoma by targeting disabled 2. Thoracic Cancer 2015; 6(4): 524 doi: 10.1111/1759-7714.12242
|
22 |
Antoine G. van der Heijden, Lourdes Mengual, Juan J. Lozano, Mercedes Ingelmo-Torres, Maria J. Ribal, Pedro L. Fernández, Egbert Oosterwijk, Jack A. Schalken, Antonio Alcaraz, J. Alfred Witjes. A five-gene expression signature to predict progression in T1G3 bladder cancer. European Journal of Cancer 2016; 64: 127 doi: 10.1016/j.ejca.2016.06.003
|
23 |
J C Martin, B-S Herbert, B A Hocevar. Disabled-2 downregulation promotes epithelial-to-mesenchymal transition. British Journal of Cancer 2010; 103(11): 1716 doi: 10.1038/sj.bjc.6605975
|
24 |
Jose A. Karam, Shahrokh F. Shariat, Hong-Ying Huang, Rey-Chen Pong, Raheela Ashfaq, Ellen Shapiro, Yair Lotan, Arthur I. Sagalowsky, Xue-Ru Wu, Jer-Tsong Hsieh. Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the Bladder. Clinical Cancer Research 2007; 13(15): 4400 doi: 10.1158/1078-0432.CCR-07-0287
|
25 |
Showket Hussain, Neha Singh, Irfana Salam, Kapil Bandil, M Yuvaraj, Mohammad Akbar Bhat, Mohammad Muzaffar Mir, Mushtaq A. Siddiqi, Ranbir C Sobti, Mausumi Bharadwaj, Bhudev C. Das. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley. Journal of Receptors and Signal Transduction 2011; 31(2): 147 doi: 10.3109/10799893.2011.553836
|
26 |
Wensi Tao, Robert Moore, Elizabeth R. Smith, Xiang-Xi Xu. Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice. Frontiers in Cell and Developmental Biology 2016; 4 doi: 10.3389/fcell.2016.00129
|
27 |
Ovidio Jiménez Martín, Andreas Schlosser, Rhoikos Furtwängler, Jenny Wegert, Manfred Gessler. MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02259-2
|
28 |
Hong-Tao Xu, Lian-He Yang, Qing-Chang Li, Shu-Li Liu, Di Liu, Xue-Mei Xie, En-Hua Wang. Disabled-2 and Axin are concurrently colocalized and underexpressed in lung cancers. Human Pathology 2011; 42(10): 1491 doi: 10.1016/j.humpath.2011.01.004
|
29 |
Chen-Shuan Chung, Yi-Chia Lee, Cheng-Ping Wang, Jenq-Yuh Ko, Wen-Lun Wang, Ming-Shiang Wu, Hsiu-Po Wang. Secondary Prevention of Esophageal Squamous Cell Carcinoma in Areas Where Smoking, Alcohol, and Betel Quid Chewing are Prevalent. Journal of the Formosan Medical Association 2010; 109(6): 408 doi: 10.1016/S0929-6646(10)60072-1
|
30 |
Yu Liu, Lili Du, Shifeng Gu, Jingying Liang, Minshan Huang, Lijun Huang, Siying Lai, Shuang Zhang, Zhaowei Tu, Wei Sun, Dunjin Chen, Jingsi Chen. Identification of the role of DAB2 and CXCL8 in uterine spiral artery remodeling in early-onset preeclampsia. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05212-4
|
31 |
Carla V. Finkielstein, Daniel G. S. Capelluto. Disabled‐2: A modular scaffold protein with multifaceted functions in signaling. BioEssays 2016; 38(S1) doi: 10.1002/bies.201670907
|
32 |
Shantel B. Ternes, Matthew J. Rowling. Vitamin D Transport Proteins Megalin and Disabled-2 Are Expressed in Prostate and Colon Epithelial Cells and Are Induced and Activated by All-Trans-Retinoic Acid. Nutrition and Cancer 2013; 65(6): 900 doi: 10.1080/01635581.2013.805422
|
33 |
O.I. Kit, D.I. Vodolazhskiy, E.N. Kolesnikov, N.N. Timoshkina. Epigenetic markers of esophageal cancer: DNA methylation. Biomeditsinskaya Khimiya 2016; 62(5): 520 doi: 10.18097/PBMC20166205520
|
34 |
Yujuan Yang, Qingxia Zhang, Feng Xu, Chunkang Chang, Xiao Li. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome. European Journal of Haematology 2012; 89(6): 469 doi: 10.1111/ejh.12014
|
35 |
Chien‐Ling Huang, Ju‐Chien Cheng, Kenji Kitajima, Toru Nakano, Chun‐Fung Yeh, Kowit‐Yu Chong, Ching‐Ping Tseng. Disabled‐2 is required for mesoderm differentiation of murine embryonic stem cells. Journal of Cellular Physiology 2010; 225(1): 92 doi: 10.1002/jcp.22200
|
36 |
Andrew M. Kaz, William M. Grady. Epigenetic biomarkers in esophageal cancer. Cancer Letters 2014; 342(2): 193 doi: 10.1016/j.canlet.2012.02.036
|
37 |
Carla V. Finkielstein, Daniel G. S. Capelluto. Disabled‐2: A modular scaffold protein with multifaceted functions in signaling. BioEssays 2016; 38(S1) doi: 10.1002/bies.201670907
|
38 |
Jaroslaw Paluszczak, Katarzyna Kiwerska, Daniela Mielcarek-Kuchta. Frequent methylation of DAB2, a Wnt pathway antagonist, in oral and oropharyngeal squamous cell carcinomas. Pathology - Research and Practice 2018; 214(2): 314 doi: 10.1016/j.prp.2017.12.010
|
39 |
Stella C. Ogbu, Phillip R. Musich, Jinyu Zhang, Zhi Q. Yao, Philip H. Howe, Yong Jiang. The role of disabled-2 (Dab2) in diseases. Gene 2021; 769: 145202 doi: 10.1016/j.gene.2020.145202
|
40 |
Roman Muff, Ram Mohan Ram Kumar, Sander M. Botter, Walter Born, Bruno Fuchs. Genes Regulated in Metastatic Osteosarcoma: Evaluation by Microarray Analysis in Four Human and Two Mouse Cell Line Systems. Sarcoma 2012; 2012: 1 doi: 10.1155/2012/937506
|
41 |
Xiao-Mei Zhang, Ming-Zhou Guo. The value of epigenetic markers in esophageal cancer. Frontiers of Medicine in China 2010; 4(4): 378 doi: 10.1007/s11684-010-0230-3
|
42 |
Wen-Lun Wang, Wei-Lun Chang, Hsiao-Bai Yang, Yu-Chi Wang, I-Wei Chang, Ching-Tai Lee, Chi-Yang Chang, Jaw-Town Lin, Bor-Shyang Sheu. Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma. Oncotarget 2016; 7(44): 71169 doi: 10.18632/oncotarget.8460
|
43 |
Milad Ashrafizadeh, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh, Saeed Samarghandian. Flaming the fight against cancer cells: the role of microRNA-93. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01349-x
|
44 |
Paulette Mhawech-Fauceglia, Joshua Kesterson, Dan Wang, Stacey Akers, Nefertiti Chianti DuPont, Kimberly Clark, Shashikant Lele, Song Liu. Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer. Histopathology 2011; 59(1): 63 doi: 10.1111/j.1365-2559.2011.03892.x
|